Allergy Therapeutics PLC (LON:AGY)

Allergy Therapeutics PLC (LON:AGY)


Share Price
11.75 p
Change
0 (0.00 %)
Market Cap
£74.75 m
Proactive Investors - Run By Investors For Investors

Allergy Therapeutics PLC

www.allergytherapeutics.com

Overview

Figures in £(m) unless stated
Sales 68.346
EBITDA -4.556
Operating Profit -6.730
Pre-tax Profit -6.896
Net Profit -7.533
Capex -2.184
Operating Cash Flow -3.802
Net Working Capital 16.297
Key Ratios
EBITDA Margin -6.666
Operating Profit Margin -0.098 -%
Net Profit Margin -0.110 -%
Capex/Sales (%) 0.032
NWC/Sales (%) -11.021859362655
Asset Turnover 1.263
Days Inventory 174.766  days
Days Receivable 21.680  days
Days Payable 65.156  days
Performance (Last 3 Years)
Sales CAGR 0.165
EBITDA CAGR n/a
Operating Profit CAGR -
Profit CAGR -
Return on Equity(%) -28.427
Return on Assets(%) -13.924
Return on Invested Capital (ROIC)(%) -24.823
ROIC - WACC n/a
Valuation
Market Cap -
Price to Earnings 0.000
Price to Book Value 1.681
Price to Tangible Book -
Equity to FCF Yield -1226.3157894737
Enterprise Value -
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield -
Payout Ratio 0
Per Share Data (in GBp unless stated)
Earnings per share -0.012700
Operating Cashflow per share -0.0063888529471567
Free Cashflow per share -0.005700
Dividend per share -
NAV per share -
Cash per share -0.002600
Solvency
Intangibles Incl. Excl.
Net debt to Equity % -54.159069202049 -68.979817528338
Cash to Equity % 67.435095945125 -494899932.5649
Gross debt to Equity % 13.276026743075 16.909040641416
Gross Debt < 1 Year to Equity 2.7958669792481 3.5609621233066
Net debt to Assets % 5.9941978986984 6.6381574662991
Net Debt/EBITDA 273.81474978051 -0
Net Interest Cover -20.550000 n/a
Op Cashflow Interest Cover -11.88125 n/a
Current Ratio 2.113868 n/a
Quick Ratio 1.472490 n/a
Cash Ratio - n/a (Intangibles collected as non-current)
Dividend Cover - n/a
Key Dates
Latest Dividend Pay date n/a
Latest Ex-Dividend date n/a
Last Annual Results 2018-10-23
Last Interim Results 2018-10-23

Profit/Loss

Figures in £(m) unless stated30/06/1830/06/1730/06/1630/06/1530/06/1430/06/1330/06/12
Sales 68.34664.13848.50943.23041.95539.27941.280
Cost of Goods Sold 17.01316.77114.07012.17911.95111.95313.670
Gross Profit 51.33347.36734.43931.05130.00427.32627.610
Operating Expenses 58.06349.26346.39030.32628.79526.65826.518
EBITDA -4.5560.191-10.1052.1652.6792.1783.900
Depreciation & Amortisation -------
EBIT (Operating Profit) -6.730-1.896-11.9510.7251.2090.6681.092
Interest Expense/Income 0.1790.0910.1530.1140.2040.3851.363
Profit Before Tax -6.896-1.970-12.0640.6541.0840.4320.640
Taxes on Income 0.6370.5111.0080.5460.343-0.104-0.183
Net Profit -7.533-2.481-13.0720.1080.7410.5360.823
Net Margin -0.110-0.039-0.2690.0020.0180.0140.020
Net profit/loss per share
Basic EPS -0.013-0.004-0.0230.0000.0020.0010.003
Diluted EPS -0.013-0.004-0.0230.0000.0020.0010.002

Balance sheet

 
Figures in £(m) unless stated 30/06/1830/06/1730/06/1630/06/1530/06/1430/06/1330/06/12
ASSETS        
Tangible Assets -------
Intangible Assets 4.9495.4595.3555.0003.7713.9104.596
Investments -------
Total Fixed Assets 20.08819.72419.06716.91014.18714.50614.720
Stocks 8.8087.4847.6926.7476.4696.0146.651
Debtors 3.7834.3364.6783.0872.7563.1294.997
Cash & Equivalents -------
Total Current Assets 30.92837.45937.61233.78914.21114.45813.034
Other Assets n/a        
Total Assets 51.01657.18356.67950.69928.39828.96427.754
LIABILITIES        
Interest bearing debt < 1 year 0.6440.3910.2950.2510.0490.288
Other Trade Creditors < 1 year -------
Total Creditors within 1 year 14.63114.02012.5207.4206.4747.6207.747
Interest bearing debt > 1 year 2.4142.9363.0701.433-0.0000.097
Other Trade Creditors > 1 year -------
Total Creditors > 1 year 0.0000.0000.0000.0000.0000.0000.000
Other Liabilities  n/a        
Total Liabilities 27.98227.21826.35516.23013.32314.29313.162
Net Assets(NET Tangible Assets exist) 18.08524.50624.96929.46911.30410.7619.996
EQUITY        
Called up share capital 0.6060.6040.5990.5560.4200.4200.417
Share Premium 102.420102.420102.39291.46367.71667.71667.571
Profit / loss -121.750-114.434-113.906-99.374-98.530-99.458-100.129
Other Equity 41.75841.37541.23941.82445.46945.99346.733
Shareholders Funds 23.03429.96530.32434.46915.07514.67114.592
Preference Stock -------
Total Capital Employed 23.03429.96530.32434.46915.07514.67114.592

Cash flow

Figures in £(m) unless stated 30/06/1830/06/1730/06/1630/06/1530/06/1430/06/1330/06/12
EBITDA -6.896-1.970-12.0640.6541.0840.4320.640
Change in Working Capital 0.2112.161-1.4500.2070.153-0.6510.917
Cash Taxes Paid -------
Cash Interest Paid/Received -------
Other (incl. non-cash items) -0.318-0.222-0.388-0.304-0.102-0.211-0.051
Net Cash from Operating Activities -3.8020.178-11.8392.0052.1732.4322.880
Capital Expenditure -2.184-1.726-1.232-1.104-0.920-0.821-1.261
Acquisitions/Disposals -------
Other Investing Activities -------
Net Cashflow from Investing Activities -2.503-1.943-1.492-2.666-1.130-1.157-1.567
Dividends -------
Increase/Decrease in Debt -0.296-0.2211.572--0.000-15.349
Increase/Decrease in Equity 0.0020.03310.96720.0790.0000.14812.614
Other Financing Activities 0.0000.0000.000--0.0000.000
Cash from Financing -0.294-0.18812.53920.0790.0000.148-2.735
Net increase in cash -6.599-1.953-0.79219.4181.0431.423-1.422

Directors dealings

Date Director Trans Amount Type Price(p) Value (£) Holding %
- Mr. Manuel Llobet - - Incentives - - 5645423.00
- Mr. Nicolas Alexander Ulrich Wykeman - - Incentives - - 1322500.00
- Dr. Babatunde Adekunle Otulana - - 0.1p Ords - - 50000.00 0.0083869
- Mr. Stephen Rushworth Smith - - 0.1p Ords - - 776513.00 0.1302506
- Mr. Manuel Llobet - - Incentives - - 8780423.00
- Mr. Nicolas Alexander Ulrich Wykeman - - Incentives - - 872500.00
2018-10-23 Mr. Peter Sinclair Jensen P 20000.00 0.1p Ords 18 3600 170000.00 0.0285154
2018-10-23 Mr. Manuel Llobet P 50000.00 0.1p Ords 17.5 8750 3325000.00 0.5577281
2018-10-23 Mr. Nicolas Alexander Ulrich Wykeman P 150000.00 0.1p Ords 17.5 26250 300000.00 0.0503213
2018-03-15 Dr. Babatunde Adekunle Otulana P 25000.00 0.1p Ords 38.8 9700 50000.00 0.0083869
- Mr. Peter Sinclair Jensen - - 0.1p Ords - - 150000.00 0.0251607
- Mr. Stephen Rushworth Smith - - 0.1p Ords - - 776513.00 0.1302506
- Mr. Manuel Llobet - - 0.1p Ords - - 3275000.00 0.5493412
- Mr. Nicolas Alexander Ulrich Wykeman - - 0.1p Ords - - 150000.00 0.0251607
- Mr. Manuel Llobet - - Incentives - - 7254024.00
2017-10-11 Dr. Babatunde Adekunle Otulana P 25000.00 0.1p Ords 50.66 12665 25000.00 0.0042079
2016-09-29 Mr. Peter Sinclair Jensen P 30000.00 0.1p Ords 19.25 5775 150000.00 0.0252475
2016-09-27 Mr. Nicolas Alexander Ulrich Wykeman P 150000.00 0.1p Ords 17.75 26625 150000.00 0.0252475
- Mr. Peter Sinclair Jensen - - 0.1p Ords - - 120000.00 0.0203416
- Mr. Stephen Rushworth Smith - - 0.1p Ords - - 776513.00 0.1307002
- Mr. Manuel Llobet - - Incentives - - 7254024.00
- Mr. Manuel Llobet - - 0.1p Ords - - 3175000.00 0.5382058
2016-09-26 Mr. Manuel Llobet P 100000.00 0.1p Ords 18 18000 3275000.00 0.5512375
- Mr. Ian David Postlethwaite - - 0.1p Ords - - 1360000.00 0.2281234

Dividends

Temporarily not available. Please try again later.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use